IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo

Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled – MS arising during Tocilizumab therapy for rheumatoid arthritis

(2016) Manuel Comabella   Multiple Sclerosis Journal

MS arising during Tocilizumab therapy for rheumatoid arthritis

(2016) Philippe Beauchemin et al.   Multiple Sclerosis Journal

Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled – MS arising during Tocilizumab therapy for rheumatoid arthritis

(2016) Manuel Comabella   Multiple Sclerosis Journal

MS arising during Tocilizumab therapy for rheumatoid arthritis

(2016) Philippe Beauchemin et al.   Multiple Sclerosis Journal

Novel Molecular Insights into Classical and Alternative Activation States of Microglia as Revealed by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based Proteomics

(2015) Harris Bell-Temin et al.   MOLECULAR & CELLULAR PROTEOMICS

TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects

(2015) L. Probert   NEUROSCIENCE

Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines

(2014) Peter J. Murray et al.   IMMUNITY

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin

(2014) Jan Mauer et al.   NATURE IMMUNOLOGY

Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study

(2014) M. Araki et al.   NEUROLOGY

Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities

(2013) Jürgen Scheller et al.   SEMINARS IN IMMUNOLOGY

Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia

(2012) C Maiorino et al.   GENE THERAPY

Interleukin-6, a mental cytokine

(2011) Anneleen Spooren et al.   BRAIN RESEARCH REVIEWS

Macrophage Diversity Enhances Tumor Progression and Metastasis

(2010) Bin-Zhi Qian et al.   CELL

IL-17- and IFN- -Secreting Foxp3+ T Cells Infiltrate the Target Tissue in Experimental Autoimmunity

(2010) M. Esposito et al.   JOURNAL OF IMMUNOLOGY

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

(2010) Subhra K Biswas et al.   NATURE IMMUNOLOGY

Site-Specific Production of IL-6 in the Central Nervous System Retargets and Enhances the Inflammatory Response in Experimental Autoimmune Encephalomyelitis

(2009) A. Quintana et al.   JOURNAL OF IMMUNOLOGY

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis

(2008) E Butti et al.   GENE THERAPY

Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging

(2008) Kurt Baeten et al.   JOURNAL OF NEUROIMMUNOLOGY

IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier

(2008) Ralf A. Linker et al.   JOURNAL OF NEUROIMMUNOLOGY

IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis

(2008) Satoshi Serada et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

(2008) T. Korn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA